In conclusion, high TMB can predict an increase in PFS after PD-1/PD-L1 inhibitor treatment for NSCLC, but its predictive value for OS, ORR, and long-term survival requires further research. The gene discussed is CD274; the disease is non-small cell lung carcinoma.